Synopsis
Synopsis
0
USDMF
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Dimethindene
2. Dimethpyrindene
3. Dimetindene
4. Fenistil
5. Forhistal
6. Maleate, Dimethindene
1. Dimetindene Maleate
2. 3614-69-5
3. Forhistal Maleate
4. Dimethpyrindene Maleate
5. Fenistil-retard
6. Dimethinden Maleate
7. Fenistil
8. Su-6518
9. Dimethindene Maleate [usan]
10. Su 6518
11. Dimethindene (maleate)
12. Nsc-107677
13. Mls002704010
14. 6ll60j9e0o
15. 2-(1-(2-(2-(dimethylamino)ethyl)inden-3-yl)ethyl)pyridine Maleate (1:1)
16. Triten
17. (z)-but-2-enedioic Acid;n,n-dimethyl-2-[3-(1-pyridin-2-ylethyl)-1h-inden-2-yl]ethanamine
18. 1h-indene-2-ethanamine, N,n-dimethyl-3-(1-(2-pyridinyl)ethyl)-, (z)-2-butenedioate (1:1)
19. Forthistal Maleate
20. Dimethindene Malenate
21. Dimetindene Maleate (jan)
22. But-2-enedioic Acid;n,n-dimethyl-2-[3-(1-pyridin-2-ylethyl)-1h-inden-2-yl]ethanamine
23. Dimethindene Maleate (usan)
24. Dimetindene Hydrogen Maleate
25. Dimetindene Maleate [jan]
26. N,n-dimethyl-2-(3-(1-(pyridin-2-yl)ethyl)-1h-inden-2-yl)ethanamine Maleate
27. Nsc107677
28. Einecs 222-789-2
29. Nsc 107677
30. Unii-6ll60j9e0o
31. Dimethindenmaleat
32. 2-[1-[2-[2-(dimethylamino)ethyl]inden-3-yl]ethyl]pyridine Maleate (1:1)
33. Dimethindene Maleate [usan:usp]
34. Starbld0026265
35. Forhistal Maleate (tn)
36. 2-(1-(2-(2-(dimethylamino)ethyl)inden-3-yl)ethyl)pyridine Maleate
37. Schembl359490
38. Chembl1870768
39. Chebi:31500
40. Dimethindene Maleate [mi]
41. Dimetindene Maleate [mart.]
42. Dimetindene Maleate [who-dd]
43. Hy-13710a
44. Mfcd00072146
45. Pyridine, 2-(1-(2-(2-(dimethylamino)ethyl)inden-3-yl)ethyl)-, Maleate (1:1)
46. Dimetindene Maleate [ep Monograph]
47. Smr001570719
48. Ws-01911
49. Cs-0015467
50. Z 820
51. D01343
52. F16365
53. W-106641
54. Q27265113
55. 1h-indene-2-ethanamine,n-dimethyl-3-[1-(2-pyridinyl)ethyl]-, (z)-2-butenedioate (1:1)
56. N,n-dimethyl-2-{3-[(rs)-1-(pyridine-2-yl)ethyl]-1h-inden-2-yl}ethanamin-(z)-butendioate
| Molecular Weight | 408.5 g/mol |
|---|---|
| Molecular Formula | C24H28N2O4 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 7 |
| Exact Mass | 408.20490738 g/mol |
| Monoisotopic Mass | 408.20490738 g/mol |
| Topological Polar Surface Area | 90.7 Ų |
| Heavy Atom Count | 30 |
| Formal Charge | 0 |
| Complexity | 518 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Antipruritics
Agents, usually topical, that relieve itching (pruritus). (See all compounds classified as Antipruritics.)
Histamine H1 Antagonists
Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)
Anti-Allergic Agents
Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Dimetindene manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dimetindene, including repackagers and relabelers. The FDA regulates Dimetindene manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dimetindene API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Dimetindene manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Dimetindene supplier is an individual or a company that provides Dimetindene active pharmaceutical ingredient (API) or Dimetindene finished formulations upon request. The Dimetindene suppliers may include Dimetindene API manufacturers, exporters, distributors and traders.
click here to find a list of Dimetindene suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Dimetindene CEP of the European Pharmacopoeia monograph is often referred to as a Dimetindene Certificate of Suitability (COS). The purpose of a Dimetindene CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Dimetindene EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Dimetindene to their clients by showing that a Dimetindene CEP has been issued for it. The manufacturer submits a Dimetindene CEP (COS) as part of the market authorization procedure, and it takes on the role of a Dimetindene CEP holder for the record. Additionally, the data presented in the Dimetindene CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Dimetindene DMF.
A Dimetindene CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Dimetindene CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Dimetindene suppliers with CEP (COS) on PharmaCompass.
A Dimetindene written confirmation (Dimetindene WC) is an official document issued by a regulatory agency to a Dimetindene manufacturer, verifying that the manufacturing facility of a Dimetindene active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Dimetindene APIs or Dimetindene finished pharmaceutical products to another nation, regulatory agencies frequently require a Dimetindene WC (written confirmation) as part of the regulatory process.
click here to find a list of Dimetindene suppliers with Written Confirmation (WC) on PharmaCompass.
Dimetindene Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dimetindene GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dimetindene GMP manufacturer or Dimetindene GMP API supplier for your needs.
A Dimetindene CoA (Certificate of Analysis) is a formal document that attests to Dimetindene's compliance with Dimetindene specifications and serves as a tool for batch-level quality control.
Dimetindene CoA mostly includes findings from lab analyses of a specific batch. For each Dimetindene CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dimetindene may be tested according to a variety of international standards, such as European Pharmacopoeia (Dimetindene EP), Dimetindene JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dimetindene USP).
LOOKING FOR A SUPPLIER?
